Clinical Trial Update: Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the foldable capsular vitreous body for safety and preliminary efficacy in severe retinal detachment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Detachment

Drugs mentioned

• Foldable Capsular Vitreous Body (foldable capsular vitreous body)

Snippet

Sponsor: GuangZhou WeiShiBo Biotechnology Co., ltd | Conditions: Retinal Detachment | Phase 1 | Status: UNKNOWN